Bausch Health Companies Insider Trading

Bausch Health Companies is a multinational pharmaceutical and medical device company headquartered in Laval, Quebec, Canada. The company develops, manufactures, and markets prescription drugs, over-the-counter medications, and medical devices across multiple therapeutic areas including dermatology, gastroenterology, neurology, and ophthalmology. Bausch Health operates through several key divisions: Bausch + Lomb for eye health products including contact lenses, surgical equipment, and pharmaceuticals; Salix Pharmaceuticals focusing on gastrointestinal treatments; Ortho Dermatologics for prescription dermatology products; and International Rx for global pharmaceutical operations. The company’s notable products include Xifaxan for irritable bowel syndrome, Jublia for toenail fungus, and various Bausch + Lomb eye care solutions. Bausch Health has manufacturing facilities and commercial operations in over 40 countries, with significant presence in North America, Europe, Asia-Pacific, and Latin America. The company was formerly known as Valeant Pharmaceuticals International and underwent significant restructuring following accounting scandals in the mid-2010s. Under new leadership, Bausch Health has focused on debt reduction, portfolio optimization, and rebuilding its reputation while maintaining its position as a major player in specialty pharmaceuticals and eye health products.